Wegovy Plateau: Is It Time to Adjust Your Dose or Stop

A Wegovy plateau — where weight loss slows significantly or stops — is common and does not automatically mean the medication has failed you. Most people experience a natural slowdown as the body adapts, but a true stall lasting more than four to eight weeks may signal it is time to revisit your dose, your lifestyle habits, or both with your prescriber.

What Is a Wegovy Weight Loss Plateau?

A plateau means your scale has stayed roughly the same for an extended period despite continuing your medication. Some slowdown is completely expected: your body adjusts its resting metabolic rate as you lose weight, meaning fewer calories are needed to maintain your new, lower mass. This is a well-documented physiological response, not a personal failure.

In the landmark STEP 1 trial published in The New England Journal of Medicine (Wilding et al., 2021), participants on 2.4 mg semaglutide lost an average of 14.9% of body weight over 68 weeks. Weight loss was not linear — it tapered noticeably after approximately week 60, which researchers recognized as a characteristic pattern of the drug. A true plateau is generally defined as less than 0.5 lb per week over four to eight consecutive weeks after reaching your maintenance dose.

What Causes a Plateau on Wegovy?

Several factors can stall progress:

• Metabolic adaptation: As body weight drops, total daily energy expenditure decreases. The FDA-approved prescribing information acknowledges that weight loss typically plateaus after the maintenance dose is reached.
• Calorie creep: Appetite suppression may feel less dramatic over time, leading to a gradual, unnoticed increase in food intake.
• Reduced physical activity: Early fatigue or nausea during dose escalation can reduce activity levels, lowering calorie burn.
• Dose not yet optimized: If you have not yet reached the full 2.4 mg maintenance dose, your current dose may not be delivering maximum effect.
• Non-medication factors: Poor sleep, chronic stress, and certain other medications (such as corticosteroids or antidepressants) can all independently inhibit weight loss.

How Does the Wegovy Dose Escalation Schedule Work?

Wegovy follows a structured escalation designed to minimize side effects while building toward the full therapeutic dose. According to the FDA-approved prescribing information, the schedule is as follows:

If you are experiencing a plateau before reaching 2.4 mg, your prescriber may recommend continuing the escalation rather than making any other changes.

Should You Adjust Your Dose or Stop?

The answer depends heavily on where you are in your treatment and what your goals are. Here is how to think through each option:

Adjusting your dose

If you are tolerating your current dose well but have plateaued before reaching 2.4 mg, moving to the next step in the escalation schedule may restore momentum. If you are already on 2.4 mg, there is no FDA-approved dose above this level for Wegovy. In that case, your prescriber might explore whether a different GLP-1 receptor agonist — such as tirzepatide (Zepbound), which targets both GLP-1 and GIP receptors — could provide additional benefit.

Staying at your current dose

A plateau after many months at 2.4 mg may simply represent your new biological set point. Continued use at the maintenance dose can help you preserve the weight you have already lost, even when the scale stops moving. The STEP 5 trial showed benefit from semaglutide over two years, suggesting long-term use remains valuable even when active loss slows.

Stopping Wegovy

Stopping is a valid choice for some people — for example, if side effects are unmanageable, if you have achieved your clinical weight goals, or if cost and access are prohibitive. However, the NIH and FDA prescribing information both note that obesity is a chronic condition, and discontinuation typically leads to weight regain. If you choose to stop, your prescriber can help you plan a structured approach to maintain your results through diet, physical activity, and monitoring.

What Can You Do Right Now to Break a Plateau?

Before changing your medication, consider these evidence-informed strategies:

• Track your food intake honestly for two weeks. Research consistently shows that people underestimate calorie consumption by 20–40%.
• Increase protein intake to support muscle retention, which helps maintain metabolic rate during weight loss.
• Add or vary resistance training. Muscle mass supports resting metabolism, counteracting some of the metabolic adaptation that causes plateaus.
• Review your sleep. Poor sleep raises ghrelin (the hunger hormone) and impairs the appetite-suppressing effects of GLP-1 medications.
• Check for interfering medications with your prescriber, including antipsychotics, certain antidepressants, and steroids that promote weight gain.

Frequently Asked Questions

Navigating a Wegovy plateau can feel discouraging, but it is a normal part of long-term weight management rather than a sign that treatment has failed. Whether the right next step is optimizing your dose, adding lifestyle strategies, switching medications, or planning a thoughtful discontinuation, this decision deserves a full conversation with your prescriber — one who knows your complete medical history, your goals, and your current health markers.